Day: April 20, 2021

Vibrent Health Collaborates with VCU to Accelerate Clinical Research, Collect Genetic, Environmental and Phenotypic Data from Diverse Populations and Improve Data Sharing Across the Research Enterprise

Vibrent enables researchers to focus on the science instead of struggling with technology implementation, IT security and contracting by investing...

T3D Therapeutics, Inc.: T3D Therapeutics Announces First Patient Dosed in its Phase 2 Study of T3D-959 for the Treatment of Mild to Moderate Alzheimer’s Disease

RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 20, 2021 / T3D Therapeutics, Inc. ("T3D"), a clinical stage drug development...

error: Content is protected !!